Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Polycystic Ovary Syndrome

In brief

The purpose of this study is to determine if vitamin D will improve insulin resistance, inflammation, and overall well-being in women with PCOS.

Key facts

Study ID

NCT00907153

Run by

Milton S. Hershey Medical Center

People needed

36

Starts

2009-05-01

Expected to finish

2014-09-01

Last updated by the study team

2017-12-19

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of PCOS based on:
• Eight or fewer menstrual periods per year or spontaneous intermenstrual periods of greater than or equal to 45 days, and
• Elevated testosterone levels

You may not qualify if…

• Current Pregnancy or Nursing
• Elevated calcium
• Kidney Stones or kidney disease
• Current use of vitamin D (other than a multivitamin)
• Use of metformin or other insulin sensitizing drugs in the last 3 months
• Elevated prolactin or untreated thyroid disease
• Diabetes, Liver disease, Heart disease, or other serious medical condition

Where it is running

• Penn State College of Medicine, Penn State Milton S Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.